Biomaterial Database

Editorial: Bioavailability data--useful or useless? 1975

E G Feldmann

UI	MeSH Term	Description	Entries
D001682	Biological Availability	The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.	Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D001702	Biopharmaceutics	The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action.	Pharmaceutics,Pharmaceutic
D012957	Societies, Pharmaceutical	Societies whose membership is limited to pharmacists.	Pharmaceutic Societies,Pharmaceutic Society,Pharmaceutical Societies,Pharmaceutical Society,Pharmacy Societies,Pharmacy Society,Societies, Pharmaceutic,Societies, Pharmacy,Society, Pharmaceutic,Society, Pharmaceutical,Society, Pharmacy
D014481	United States	A country in NORTH AMERICA between CANADA and MEXICO.
D014486	United States Food and Drug Administration	An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.	Food and Drug Administration (U.S.),USFDA,Food and Drug Administration,United States Food, Drug Administration